0378-1430 : Nicardipine Hydrochloride 30 mg Oral Capsule


NDC0378-1430
Labeler: Mylan Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name:  Nicardipine Hydrochloride
Dosage Form: Oral Capsule
Application #: ANDA074642
Rev. Date: 


Appearance:


Markings: MYLAN;1430
Shapes:  Capsule
Colors:  Blue / Yellow
Size (mm): 15
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

MYLAN 1430: (0378-1430) Nicardipine Hydrochloride 30 mg Oral Capsule by Mylan Pharmaceuticals Inc.
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 0378-1430-05: 500 CAPSULE IN 1 BOTTLE, PLASTIC (0378‑1430‑05)
  • 0378-1430-77: 90 CAPSULE IN 1 BOTTLE, PLASTIC (0378‑1430‑77)

Active Ingredients:

  • Nicardipine Hydrochloride

Dosage Strength:

  • 30 mg

Inactive Ingredients:

  • Silicon Dioxide
  • Gelatin
  • Magnesium Stearate
  • Starch, Corn
  • Propylene Glycol
  • Sodium Lauryl Sulfate
  • Ferrosoferric Oxide
  • Fd&c Blue No. 2
  • Fd&c Red No. 40
  • Fd&c Blue No. 1
  • D&c Yellow No. 10
  • Titanium Dioxide
  • Ferric Oxide Yellow
  • Fd&c Green No. 3

Pharmaceutical Classes:

  • Calcium Channel Antagonists [MoA]
  • Dihydropyridine Calcium Channel Blocker [EPC]
  • Dihydropyridines [Chemical/Ingredient]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Cytochrome P450 2D6 Inhibitors [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • Cytochrome P450 2C19 Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0378-1020 Nicardipine Hydrochloride 20 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0143-9542 Nicardipine Hydrochloride 2.5 mg/ml Intravenous Injection by West-ward Pharmaceutical Corp
  • 0143-9593 Nicardipine Hydrochloride 2.5 mg/ml Intravenous Injection by West-ward Pharmaceutical Corp
  • 0143-9633 Nicardipine Hydrochloride .2 mg/ml Intravenous Injection by Hikma Pharmaceuticals USA Inc.
  • 0143-9634 Nicardipine Hydrochloride .1 mg/ml Intravenous Injection by Hikma Pharmaceuticals USA Inc.
  • 0143-9689 Nicardipine Hydrochloride 25 mg/10ml Intravenous Injection by West-ward Pharmaceutical Corp
  • 0517-0735 Nicardipine Hydrochloride 2.5 mg/ml Intravenous Injection, Solution by American Regent, Inc.
  • 0781-3204 Nicardipine Hydrochloride 2.5 mg/ml Intravenous Injection by Sandoz Inc.
  • 0781-9324 Nicardipine Hydrochloride 2.5 mg/ml Intravenous Injection by Sandoz Inc.
  • 10139-700 Nicardipine Hydrochloride 2.5 mg/ml Intravenous Injection by Generamedix Inc.
  • 14593-124 Nicardipine Hydrochloride 2.5 mg/ml Intravenous Injection by Emcure Pharmaceuticals Ltd.
  • 24658-750 Nicardipine Hydrochloride 20 mg Oral Capsule by Puracap Laboratories, LLC
  • 24658-751 Nicardipine Hydrochloride 30 mg Oral Capsule by Puracap Laboratories, LLC
  • 35573-457 Nicardipine Hydrochloride 20 mg Oral Capsule by Burel Pharmaceuticals, LLC
  • 35573-458 Nicardipine Hydrochloride 30 mg Oral Capsule by Burel Pharmaceuticals, LLC
  • 40042-047 Nicardipine Hydrochloride 2.5 mg/ml Intravenous Injection, Solution by Pharmaforce, Inc.
  • 41616-882 Nicardipine Hydrochloride 2.5 mg/ml Intravenous Injection by Sun Pharma Global Inc.
  • 42291-640 Nicardipine Hydrochloride 20 mg Oral Capsule by Avkare, Inc.
  • 42291-641 Nicardipine Hydrochloride 30 mg Oral Capsule by Avkare, Inc.
  • 42571-394 Nicardipine Hydrochloride 2.5 mg/ml Intravenous Injection by Micro Labs Limited
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0378-1430 QR Code

< Prev: 0378-1425Next: 0378-1450 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.